FILANA THERAPEUTICS, INC. Cash Flow Statement
FLNA|5 years of annual SEC 10-K data (FY2011-FY2015)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 5 fiscal years. All figures from audited SEC 10-K filings.
FILANA THERAPEUTICS, INC. used $7M in operating cash flow and negative free cash flow of $7M in FY2015.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 3.76 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|
| Net Income | $31.5M | -$3.4M | -$2.6M | -$12.0M | -$3.5M |
| Depreciation & Amortization | $15.0K | $122.0K | $163.0K | $232.0K | $257.0K |
| Operating Cash Flow | -$6.9M | -$7.2M | -$260.0K | -$143.0K | -$14.7M |
| Capital Expenditures | $80.0K | $80.0K | - | - | - |
| Free Cash Flow | -$7.0M | -$7.3M | - | - | - |
| FCF Margin | -17.1% | -66.6% | - | - | - |